157 related articles for article (PubMed ID: 10421537)
1. Does race influence survival for esophageal cancer patients treated on the radiation and chemotherapy arm of RTOG #85-01?
Streeter OE; Martz KL; Gaspar LE; Delrowe JD; Asbell SO; Salter MM; Roach M
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1047-52. PubMed ID: 10421537
[TBL] [Abstract][Full Text] [Related]
2. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
[TBL] [Abstract][Full Text] [Related]
3. Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy.
Burmeister BH; Dickie G; Smithers BM; Hodge R; Morton K
Arch Otolaryngol Head Neck Surg; 2000 Feb; 126(2):205-8. PubMed ID: 10680872
[TBL] [Abstract][Full Text] [Related]
4. Outcomes from chemoradiotherapy for patients with esophageal cancer.
Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
[TBL] [Abstract][Full Text] [Related]
5. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
Wolf M; Zehentmayr F; Niyazi M; Ganswindt U; Haimerl W; Schmidt M; Hölzel D; Belka C
Strahlenther Onkol; 2010 Jul; 186(7):374-81. PubMed ID: 20582393
[TBL] [Abstract][Full Text] [Related]
7. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.
Valencia Julve J; Alonso Orduña V; Escó Barón R; López-Mata M; Méndez Villamón A
Clin Transl Oncol; 2006 Jan; 8(1):22-30. PubMed ID: 16632436
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in esophageal cancer treatment and outcomes.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; McGinn TG; Wisnivesky JP
Ann Surg Oncol; 2008 Mar; 15(3):881-8. PubMed ID: 17987341
[TBL] [Abstract][Full Text] [Related]
11. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
[TBL] [Abstract][Full Text] [Related]
14. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus.
Minsky BD; Neuberg D; Kelsen DP; Pisansky TM; Ginsberg RJ; Pajak T; Salter M; Benson AB
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):517-23. PubMed ID: 10078631
[TBL] [Abstract][Full Text] [Related]
15. Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology.
Baquet CR; Commiskey P; Mack K; Meltzer S; Mishra SI
J Natl Med Assoc; 2005 Nov; 97(11):1471-8. PubMed ID: 16334494
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in esophageal cancer survival after surgery.
Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Bhora F; Flores RM
J Surg Oncol; 2016 May; 113(6):659-64. PubMed ID: 26865174
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.
Suntharalingam M; Winter K; Ilson D; Dicker AP; Kachnic L; Konski A; Chakravarthy AB; Anker CJ; Thakrar H; Horiba N; Dubey A; Greenberger JS; Raben A; Giguere J; Roof K; Videtic G; Pollock J; Safran H; Crane CH
JAMA Oncol; 2017 Nov; 3(11):1520-1528. PubMed ID: 28687830
[TBL] [Abstract][Full Text] [Related]
18. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
Coia LR; Engstrom PF; Paul A
J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
[TBL] [Abstract][Full Text] [Related]
19. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.
Wu X; Chen VW; Andrews PA; Ruiz B; Correa P
Cancer Causes Control; 2007 Aug; 18(6):585-93. PubMed ID: 17406989
[TBL] [Abstract][Full Text] [Related]
20. A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
Swisher SG; Winter KA; Komaki RU; Ajani JA; Wu TT; Hofstetter WL; Konski AA; Willett CG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1967-72. PubMed ID: 21507583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]